hotspot -WSS

hotspot

author：fashion 2025-09-29 13:46:10 - browse：32966

Are there still too many biotech companies? How do you know when you’re in a bubble? And is there a wrong way to pronounce “TIGIT”?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Josh Schimmer and Eric Schmidt, two longtime analysts teaming up at Cantor Fitzgerald, join us for a back-to-school conversation as biotech enters the busy back third of 2023. We also discuss the latest news in the life sciences, including some scientific evolution at Biogen, new leadership at Illumina, and the future of CRISPR medicine.

For more on what we cover, here’s the news from Biogen; here’s more on Illumina; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： New case study details death in closely watched Alzhiemer's trial

focus

WSS

Timeline: How the deadly wildfires took over Maui day by day

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Montana youths win climate lawsuit against state for promoting fossil fuels

A new study asks: Are we harming blood donors by taking blood?

BMS, looking to build heart drug business, turns to AI for diagnosis

New case study details death in closely watched Alzhiemer's trial

explore

hotspot

Wikipedia

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Make 'food is medicine' a key part of White House nutrition meeting

Trump demands the U.S. pay no more for drugs than other countries … again

Maui wildfire now ranks as the fifth

At least 13 dead in Texas as scorching temps continue

Aspartame and sugar

Apple is now the first public company to be valued at $3 trillion

Indictment alleges Trump's ex

Bright Health sells Medicare Advantage business to Molina

PhRMA sues HHS over Medicare drug price negotiation

hotspot

Can food be medicine? And other questions about a new push

7 people shot in DC, police say

Judge sides with young activists in first

Meta looks to target Twitter with a rival app called Threads

YouTube cracks down on misinformation on cancer treatment

A new study asks: Are we harming blood donors by taking blood?

knowledge

focus

entertainment

explore